Polymorphisms in NF-κB pathway genes & their association with risk of lung cancer in the chinese population

Pakistan Journal of Medical Sciences

Volumn 31, Issue 6, 2015, Pages 1411-1416

  Zhang, Jing Wei ^a   Chen, Qiu Sheng ^a   Zhai, Jian Xia ^a   Lv, Peng Ju ^a   Sun, Xiao Yan ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Genetic variation; Lung cancer; NF B; Polymorphism; Risk

Indexed keywords

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NFKB1 GENE; NFKBIA GENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84948987437     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.316.7935     Document Type: Article

References (21)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence & Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010.
2. Wang YC, Wei LJ, Liu JT, Li SX, Wang QS. Comparison of cancer incidence between China & the USA. Cancer Biol Med. 2012;9(2):128-132.doi:10.3969/j.issn.2095-3941.2012.02.009.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74-108.
4. Marshall AL, Christiani DC. Genetic susceptibility to lung cancer--light at the end of the tunnel? Carcinogenesis. 2013;34(3):487-502.doi:10.1093/carcin/bgt016
5. Schwartz AG, Prysak GM, Bock CH, Cote ML. The molecular epidemiology of lung cancer. Carcinogenesis. 2007;28(3):507-518.
6. Kundu JK, Surh YJ. Emerging avenues linking inflammation & cancer. Free RadicBiol Med. 2012;52(9):2013-2037. doi:10.1016/j.freeradbiomed.2012.02.035
7. DiDonato JA, Mercurio F, Karin M. NF-κB & The link between inflammation & cancer. Immunol Rev. 2012;246(1):379-400. doi:10.1111/j.1600-065X.2012.01099.x.
8. Eiró N, Vizoso FJ. Inflammation & cancer. World J Gastrointest Surg. 2012 27;4(3):62-72.
9. Tak PP, Firestein GS. NF-kappaB: A key role in inflammatory diseases. J Clin Invest. 2001;107(1):7-11.
10. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors & its regulation. Cold Spring Harb Perspect Biol. 2009;1(4):a000034. doi:10.1101/cshperspect.a000034.
11. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, et al. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery. 2001;130(2):363-369.
12. Chen CD, Sawyers CL. NF-kappa B activates prostatespecific antigen expression &is upregulated in androgen-independent prostate cancer. Mol Cell Biol. 2002;22(8):2862-2870.
13. Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci USA. 2001;98(18):10386-10391.
14. Suzairi MSM, Tan SC, Aizat AAA, Aminudin MM, Nurfatimah MSS, Andee ZD, et al. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013;37(5):634-638. doi:10.1016/j.canep.2013.05.007.
15. Tan SC, Suzairi MSM, Aizat AAA, Aminudin MM, Nurfatimah MSS, Bhavaraju VMK, et al. Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer. Med Oncol. 2013;30(4):693. doi:10.1007/s12032-013-0693-6.
16. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004;13(1):35-45.
17. Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, et al. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK & Dutch sarcoidosis. Genes Immun. 2003;4(6):450-454.
18. Huang D, Yang L, Liu Y, Zhou Y, Guo Y, Pan M, et al. Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease & lung cancer in Chinese. Hum Genet. 2013;132(4):451-460.doi:10.1007/s00439-013-1264-9.
19. Huo ZH, Zhong HJ, Zhu YS, Xing B, Tang H. Roles of functional NFKB1& β-TrCP insertion/deletion polymorphisms in mRNA expression & epithelial ovarian cancer susceptibility. Genet Mol Res. 2013;12(3):3435-3443. doi:10.4238/2013.March.11.6.
20. Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B. Association of common polymorphisms in TNFA, NFkB1&NFKBIA with risk & prognosis of esophageal squamous cell carcinoma. PLoS One. 2013;8(12):e81999. doi:10.1371/journal.pone.0081999.
21. Lin CW, Hsieh YS, Hsin CH, Su CW, Lin CH, Wei LH, et al. Effects of NFKB1&NFKBIA gene polymorphisms on susceptibility to environmental factors & the clinicopathologic development of oral cancer. PLoS One. 2012;7(4):e35078. doi:10.1371/journal.pone.0035078.